

To seek novel approaches targeting drivers of tumor evolution to overcome acquired and adaptive resistance networks to develop all the way of truly innovative cancer resistance therapies for patients.
2021-2023, Korea national funding for Ph.D. student research (2 years scholarship)
2022, S.Nam, D.Ryu, A. Park, Y. Kim, Use of biomarker ENPP7 for diagnosis and treatment of type 2 diabetes, #10-2022-0088696
2022-01, KALAS (Korean association for laboratory animal science) : SIRT7 controls the sensitivity of liver cancer to sorafenib in a nude mouse xenograft model
2019-09, KSBMB (Korean society for biochemistry and molecular biology) : A Sirt7-Dependent Deacetylation Modulates DNA Damage Repair and Loss-of-Hepatic Sirt7 Promotes Hepatocellular Carcinoma
2018-09, KDA (Korean diabetes association)
2016-01, BFDG (The British Feeding and Drinking Group) : The effect of intermittent fasting on abdominal obesity in the overweight and obese